Change the world

J2HBiotech - Journey to Healthcare Solutions

History

J2H Biotech :
A Journey of Innovation and Growth

image

image

image

image

image

  1. 2024 - 2025

    Completed Phase 2a clinical trial for MASH drug candidate

    1. Received IND approval for a multiple sclerosis treatment candidate (Phase 1 clinical trial)
    2. Selected for the National Project on Global Rare Disease Diagnosis and
      Treatment Development by the Ministry of Health and Welfare (Funding: 6 billion KRW)

    image

  2. 2022 - 2023

    Began Phase 2a clinical trial for MASH drug candidate

    1. Conducted preclinical studies for a non-small cell lung cancer treatment candidate with government project support (Funding: 2 billion KRW)
    2. Pharmaceutical Business Division (Ansan) earned GMP certification (Korean Ministry of Food and Drug Safety)
    3. Established a new development division under the R&D Center

    image

  3. 2020 - 2021

    Conducted Phase 1 clinical trial for MASH drug candidate

    1. Completed preclinical studies for a multiple sclerosis treatment candidate
    2. Received certification as an Inno-Biz technology innovation company
    3. Designated as an Excellent Corporate R&D Center (Ministry of Science and ICT)
    4. Completed construction of the Fine Chemicals Division facility in Asan;
      obtained ISO 9001 Quality Management System certification

    image

  4. 2016 - 2019

    Licensed out two new drug candidates

    1. Secured Korean Ministry of Food and Drug Safety approval for Tenofovir Disoproxil
    2. Won a patent lawsuit for a blockbuster generic against 11 pharmaceutical companies
    3. Recognized as a Preliminary Unicorn Company (Ministry of SMEs and Startups)

    image

  5. 2014 - 2015

    Founded J2H Biotech, Inc.

    1. Certified as a Company-Affiliated Research Institute (Korea Industrial Technology Association)
    2. Certified as a Venture Company (Korean Venture Capital Association)
    3. Relentless Innovation and Challenge

    image

A Journey of Innovation and Growth

Since its foundation, J2H Biotech has grown into a global healthcare solution company through technological excellence and relentless passion. We are committed to providing better lives for people around the world by advancing treatments for rare and incurable diseases through innovative drug development.